76%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
76%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
76%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
76%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
WaVe Life Sciences Ltd
Closed
7 1.89
Overview
Share price change
24h
Min
6.75
Max
7.05
Income | -76M -47M |
|---|---|
Sales | -75M 9.2M |
EPS | -0.29 |
Profit margin | -510.932 |
Employees | 287 |
EBITDA | -73M -48M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +151.82% upside |
Next Earnings | 7 Aug 2025 |
|---|
Market Cap | -36M 1B |
|---|---|
Previous open | 5.11 |
Previous close | 7 |
Technical Score
By Trading Central
Confidence
Very Strong Bearish Evidence
WaVe Life Sciences Ltd Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
WaVe Life Sciences Ltd Forecast
Price Target
By TipRanks
151.82% upside
12 Months Forecast
Average 17.25 USD 151.82%
High 24 USD
Low 9 USD
Based on 9 Wall Street analysts offering 12 month price targets forWaVe Life Sciences Ltd - Dist in the last 3 months.
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
